Prelude Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $316K | Buy |
1,130
+4
| +0.4% | +$1.05K | 0.02% | 749 |
|
|
2026
Q1 | $300K | Sell |
1,126
-380
| -25% | -$103K | 0.02% | 705 |
|
|
2025
Q4 | $378K | Buy |
+1,506
| New | +$400K | 0.03% | 670 |
|
|
2025
Q2 | – | Sell |
-952
| Closed | -$222K | – | 1194 |
|
|
2025
Q1 | $222K | Buy |
+952
| New | +$231K | 0.02% | 878 |
|
|
2022
Q3 | – | Sell |
-1,137
| Closed | -$229K | – | 1775 |
|
|
2022
Q2 | $229K | Buy |
+1,137
| New | +$242K | 0.01% | 1218 |
|
|
2022
Q1 | – | Sell |
-1,656
| Closed | -$447K | – | 2047 |
|
|
2021
Q4 | $447K | Buy |
1,656
+266
| +19% | +$65.8K | 0.01% | 1083 |
|
|
2021
Q3 | $336K | Sell |
1,390
-297
| -18% | -$74.8K | 0.01% | 1082 |
|
|
2021
Q2 | $400K | Buy |
+1,687
| New | +$384K | 0.01% | 1061 |
|
|
2020
Q4 | – | Sell |
-70
| Closed | -$11K | – | 1667 |
|
|
2020
Q3 | $11K | Buy |
+70
| New | +$11.1K | ﹤0.01% | 1443 |
|
|
2020
Q2 | – | Sell |
-1,781
| Closed | -$193K | – | 2125 |
|
|
2020
Q1 | $193K | Sell |
1,781
-56
| -3% | -$8.07K | 0.01% | 457 |
|
|
2019
Q4 | $267K | Buy |
1,837
+1,248
| +212% | +$180K | 0.01% | 764 |
|
|
2019
Q3 | $85K | Sell |
589
-144
| -20% | -$21K | ﹤0.01% | 1003 |
|
|
2019
Q2 | $109K | Buy |
+733
| New | +$102K | 0.01% | 913 |
|
|
2017
Q4 | – | Sell |
-565
| Closed | -$73K | – | 1553 |
|
|
2017
Q3 | $73K | Buy |
+565
| New | +$75.4K | 0.01% | 988 |
|
|
2017
Q2 | – | Sell |
-276
| Closed | -$34K | – | 1734 |
|
|
2017
Q1 | $34K | Sell |
276
-642
| -70% | -$76K | ﹤0.01% | 1151 |
|
|
2016
Q4 | $101K | Buy |
+918
| New | +$102K | 0.01% | 826 |
|
|
2016
Q3 | – | Sell |
-1,730
| Closed | -$194K | – | 1713 |
|
|
2016
Q2 | $194K | Buy |
1,730
+1,074
| +164% | +$116K | 0.03% | 508 |
|
|
2016
Q1 | $66K | Buy |
+656
| New | +$62.9K | 0.01% | 892 |
|
|
2015
Q4 | – | Sell |
-2,249
| Closed | -$210K | – | 1578 |
|
|
2015
Q3 | $210K | Buy |
2,249
+469
| +26% | +$48.5K | 0.03% | 566 |
|
|
2015
Q2 | $185K | Buy |
1,780
+1,141
| +179% | +$119K | 0.03% | 640 |
|
|
2015
Q1 | $69K | Buy |
+639
| New | +$65.7K | 0.01% | 1164 |
|
|
2014
Q4 | – | Sell |
-1,779
| Closed | -$155K | – | 2032 |
|
|
2014
Q3 | $155K | Buy |
1,779
+267
| +18% | +$24.1K | 0.02% | 820 |
|
|
2014
Q2 | $133K | Sell |
1,512
-10,686
| -88% | -$926K | 0.02% | 947 |
|
|
2014
Q1 | $1.03M | Buy |
12,198
+10,452
| +599% | +$833K | 0.14% | 169 |
|
|
2013
Q4 | $137K | Hold |
1,746
| – | – | 0.02% | 741 |
|
|
2013
Q3 | $149K | Hold |
1,746
| – | – | 0.02% | 623 |
|
|
2013
Q2 | $150K | Buy |
+1,746
| New | +$145K | 0.03% | 502 |
|
Other funds holding LH
Prelude Capital Management's LH Position: Q2 2026 in Review
Prelude Capital Management increased its Labcorp (LH) stake by 0.36% in Q2 2026, buying an estimated $1.05K and bringing the position to 1,130 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #749.
Prelude Capital Management first reported a position in LH in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.03M in Q1 2014. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Prelude Capital Management held 1,130 shares of Labcorp worth $316K as of Q2 2026.
- Prelude Capital Management bought 4 Labcorp shares in Q2 2026, an estimated $1.05K.
- Labcorp made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #749 holding.
- Prelude Capital Management first reported a position in Labcorp in Q2 2013 and has held it in 27 quarters since.
- Prelude Capital Management's Labcorp position peaked at $1.03M in Q1 2014.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.